CS logo
small CS logo
Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Hematologia

Debrecen, Hungary

About Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Hematologia


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Hematologia


During the past decade, Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Hematologia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Hematologia" #1 collaborator was "AbbVie" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Hematologia


According to Clinical.Site data, the most researched conditions in "Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Hematologia" are "Diffuse Large B-cell Lymphoma" (1 trials), "Myelofibrosis" (1 trials), "Post-essential Thrombocythemia Myelofibrosis" (1 trials), "Post-polycythemia Vera Myelofibrosis" (1 trials) and "Primary Myelofibrosis" (1 trials). Many other conditions were trialed in "Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Hematologia" in a lesser frequency.

Clinical Trials Intervention Types at Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Hematologia


Most popular intervention types in "Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Hematologia" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Epcoritamab" (1 trials), "Investigator's Choice Chemotherapy" (1 trials), "Pelabresib" (1 trials), "Placebo" (1 trials) and "Ruxolitinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Hematologia


The vast majority of trials in "Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Hematologia" are 2 trials for "All" genders.

Clinical Trials Status at Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Hematologia


Currently, there are NaN active trials in "Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Hematologia". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Hematologia, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Hematologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".